The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


BOCOUTURE 50 units powder for solution for injection



Merz Pharmaceuticals GmbHPA1907/003/001

Main Information

Trade NameBOCOUTURE 50 units powder for solution for injection
Active SubstancesCLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS
Dosage FormPowder for solution for injection
Licence HolderMerz Pharmaceuticals GmbH
Licence NumberPA1907/003/001

Group Information

ATC CodeM03AX01 botulinum toxin

Status

License statusAuthorised
Licence Issued12/02/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back